2012-10-05 16:43:41 - New Pharmaceuticals market report from Global Markets Direct: "Acromegaly - Pipeline Review, H2 2012"

Global Markets Direct's, 'Acromegaly - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Acromegaly, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Acromegaly. Acromegaly - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


Full Report Details at

- www.fastmr.com/prod/468410_acromegaly_pipeline_review_h2_2012.as ..


Scope

* A snapshot of the global therapeutic scenario for Acromegaly.
* A review of the Acromegaly products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
* Coverage of products based on various stages of development ranging from discovery till registration stages.
* A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
* Coverage of the Acromegaly pipeline on the basis of route of administration and molecule type.
* Key discontinued pipeline projects.
* Latest news and deals relating to the products.

Reasons to buy

* Identify and understand important and diverse types of therapeutics under development for Acromegaly.
* Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
* Plan mergers and acquisitions effectively by identifying players of the most promising pipeline.
* Devise corrective measures for pipeline projects by understanding Acromegaly pipeline depth and focus of Indication therapeutics.
* Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
* Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

Partial Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Acromegaly Overview
Therapeutics Development
An Overview of Pipeline Products for Acromegaly
Acromegaly Therapeutics under Development by Companies
Acromegaly Therapeutics under Investigation by Universities/Institutes
Late Stage Products
Comparative Analysis
Mid Clinical Stage Products
Comparative Analysis
Early Clinical Stage Products
Comparative Analysis
Discovery and Pre-Clinical Stage Products
Comparative Analysis
Acromegaly Therapeutics - Products under Development by Companies
Acromegaly Therapeutics - Products under Investigation by Universities/Institutes
Companies Involved in Acromegaly Therapeutics Development
Novartis AG
Zosano Pharma, Inc.
Antisense Therapeutics Limited
Paladin Labs Inc.
Asterion Ltd
Camurus AB
Syntaxin Ltd
Oakwood Laboratories L.L.C.
Peptron, Inc.
Acromegaly - Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Route of Administration
Assessment by Molecule Type
Drug Profiles
pasireotide - Drug Profile
Product Description
Mechanism of Action
R&D Progress
ATL-1103 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
SXN-101959 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
octreotide acetate - Drug Profile
Product Description
Mechanism of Action
R&D Progress
octreotide acetate - Drug Profile
Product Description
Mechanism of Action
R&D Progress
lanreotide acetate - Drug Profile
Product Description
Mechanism of Action
R&D Progress
octreotide acetate - Drug Profile
Product Description
Mechanism of Action
R&D Progress
octreotide acetate - Drug Profile
Product Description
Mechanism of Action
R&D Progress
GH Antagonists - Drug Profile
Product Description
Mechanism of Action
R&D Progress
octreotide acetate - Drug Profile
Product Description
Mechanism of Action
R&D Progress
FP-002 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
octreotide - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Acromegaly Therapeutics - Drug Profile Updates
Acromegaly Therapeutics - Discontinued Products
Acromegaly Therapeutics - Dormant Products
Acromegaly - Product Development Milestones
Featured News & Press Releases
Aug 07, 2012: Antisense Therapeutics Commences Start Up Activities In Phase II Clinical Trial Of ATL1103
Jun 29, 2012: Ipsen's Somatuline Receives Marketing Approval In Japan For Treatment Of Acromegaly And Pituitary Gigantism
Jun 26, 2012: Chiasma's Oral Investigational Drug Octreolin For Acromegaly Demonstrates Growth Hormone Suppression
May 07, 2012: Novartis's Pasireotide LAR Shows Superior Efficacy Compared To Sandostatin LAR In Phase III Trial Of Patients With Acromegaly
Apr 03, 2012: Antisense Therapeutics Announces Shareholder Presentations On ATL1103 Project
Dec 07, 2011: Antisense Therapeutics's ATL1103 Successfully Progresses Towards Phase II Clinical Trial
Nov 07, 2011: ANP Receives Japanese Patent For ATL1103

Full Table of Contents is available at:
-- www.fastmr.com/catalog/product.aspx?productid=468410&dt=t

About Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. View more research from Global Markets Direct at www.fastmr.com/catalog/publishers.aspx?pubid=1033

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.